These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37577040)

  • 1. Effect of Benaglutide on Gut Microbiota and Fecal Metabolites in Patients with Type 2 Diabetes Mellitus.
    Han CY; Ye XM; Lu JP; Jin HY; Wang P; Xu WW; Zhang M
    Diabetes Metab Syndr Obes; 2023; 16():2329-2344. PubMed ID: 37577040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of metformin combined with liraglutide on gut microbiota of Chinese patients with type 2 diabetes.
    Niu X; Lu P; Huang L; Sun Y; Jin M; Liu J; Li X
    Int Microbiol; 2024 Feb; 27(1):265-276. PubMed ID: 37316616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study.
    Wu Z; Zhang B; Chen F; Xia R; Zhu D; Chen B; Lin A; Zheng C; Hou D; Li X; Zhang S; Chen Y; Hou K
    Front Cell Infect Microbiol; 2022; 12():1089991. PubMed ID: 36704100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jiang-Tang-San-Huang pill alleviates type 2 diabetes mellitus through modulating the gut microbiota and bile acids metabolism.
    Tawulie D; Jin L; Shang X; Li Y; Sun L; Xie H; Zhao J; Liao J; Zhu Z; Cui H; Wen W
    Phytomedicine; 2023 May; 113():154733. PubMed ID: 36870307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study.
    Meiring S; van Baar ACG; Sørensen N; Holleman F; Soeters MR; Nieuwdorp M; Bergman JJGHM
    Front Clin Diabetes Healthc; 2022; 3():856661. PubMed ID: 36992788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.
    Ding D; Yong H; You N; Lu W; Yang X; Ye X; Wang Y; Cai T; Zheng X; Chen H; Cui B; Zhang F; Liu X; Mao JH; Lu Y; Chang H
    Front Cell Infect Microbiol; 2022; 12():820367. PubMed ID: 35402293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the Lipid Profile, Type 2 Diabetes and Medication on the Metabolic Syndrome-Associated Gut Microbiome.
    Gradisteanu Pircalabioru G; Liaw J; Gundogdu O; Corcionivoschi N; Ilie I; Oprea L; Musat M; Chifiriuc MC
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects.
    Carrizales-Sánchez AK; Tamez-Rivera O; Rodríguez-Gutiérrez NA; Elizondo-Montemayor L; Gradilla-Hernández MS; García-Rivas G; Pacheco A; Senés-Guerrero C
    BMC Pediatr; 2023 May; 23(1):210. PubMed ID: 37138212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1 receptor agonists modulate blood glucose levels in T2DM by affecting Faecalibacterium prausnitzii abundance in the intestine.
    Liang L; Rao E; Zhang X; Wu B; Su X; Chen L; Nie R; Nian X
    Medicine (Baltimore); 2023 Sep; 102(35):e34978. PubMed ID: 37657059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal metabolomics combined with 16S rRNA gene sequencing to analyze the effect of Jiaotai pill intervention in type 2 diabetes mellitus rats.
    Liu J; Wang X; Li Q; Piao C; Fan Z; Zhang Y; Yang S; Wu X
    Front Nutr; 2023; 10():1135343. PubMed ID: 37229468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
    Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
    mBio; 2018 May; 9(3):. PubMed ID: 29789365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats.
    Zhao JD; Li Y; Sun M; Yu CJ; Li JY; Wang SH; Yang D; Guo CL; Du X; Zhang WJ; Cheng RD; Diao XC; Fang ZH
    World J Gastroenterol; 2021 Feb; 27(8):708-724. PubMed ID: 33716449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
    Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
    Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered gut microbiota and metabolites in untreated myasthenia gravis patients.
    Ding XJ; Li HY; Wang H; Zhang XH; Song M; Jiang XH; Zhang X; Yue YX; Li XH
    Front Neurol; 2023; 14():1248336. PubMed ID: 37789892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human gut microbiota changes reveal the progression of glucose intolerance.
    Zhang X; Shen D; Fang Z; Jie Z; Qiu X; Zhang C; Chen Y; Ji L
    PLoS One; 2013; 8(8):e71108. PubMed ID: 24013136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated 16S rRNA Sequencing, Metagenomics, and Metabolomics to Characterize Gut Microbial Composition, Function, and Fecal Metabolic Phenotype in Non-obese Type 2 Diabetic Goto-Kakizaki Rats.
    Peng W; Huang J; Yang J; Zhang Z; Yu R; Fayyaz S; Zhang S; Qin YH
    Front Microbiol; 2019; 10():3141. PubMed ID: 32038574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between gut bacteria
    Li W; Li L; Yang F; Hu Q; Xiong D
    Ann Transl Med; 2022 Oct; 10(19):1056. PubMed ID: 36330416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles.
    Zhou R; He D; Zhang H; Xie J; Zhang S; Tian X; Zeng H; Qin Y; Huang L
    J Ethnopharmacol; 2023 Mar; 303():115997. PubMed ID: 36509256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.